Literature DB >> 28113108

The influence of TNF alpha -308 G/A polymorphism on oxidative stress in patients with chronic lymphocytic leukemia.

T Jevtovic-Stoimenov1, T Cvetkovic2, M Despotovic3, J Basic3, J Cvetkovic4, G Marjanovic5, D Pavlovic3.   

Abstract

The aim of this study was to examine the association of TNF-α-308G/A polymorphism with CLL and influence on oxidative stress parameters.Significant difference in the genotype and allele distribution was obtained in TNFA subgroup of patients.Significantly higher GPx activity and TBARS and lower catalase activity were detected in CLL.Significantly higher catalase and lower GPx activities were detected in PBMC of TNFG compared to TNFA subgroup, while TBARS were higher in TNFA.Oxidative stress in CLL patients highly correlates with the presence of TNFA subgroup. Increased TBARS, GPx and decreased catalase activity are associated with TNF-α-308A allele containing genotypes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CLL; Oxidative stress; TNF-α polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28113108     DOI: 10.1016/j.leukres.2017.01.018

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia

Authors:  Yasser B.M Ali; Rasha M Foad; Essam Abdel-Wahed
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

2.  Clinical Relevance of +936 C>T VEGFA and c.233C>T bFGF Polymorphisms in Chronic Lymphocytic Leukemia.

Authors:  Sandra Ballester; Begoña Pineda; Patricia Rodrigues; Eduardo Tormo; María José Terol; Pilar Eroles
Journal:  Genes (Basel)       Date:  2020-06-23       Impact factor: 4.096

3.  Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia.

Authors:  Claudia Bănescu; Florin Tripon; Adrian P Trifa; Andrei G Crauciuc; Valeriu G Moldovan; Alina Bogliş; Istvan Benedek; Delia Dima; Marcela Cândea; Carmen Duicu; Mihaela Iancu
Journal:  Cancer Med       Date:  2019-08-01       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.